Table 2.
Parameters | Total (n = 819) |
Survivors (n = 720) |
Nonsurvivors (n = 99) |
P |
---|---|---|---|---|
CRP (mg/L) | 55 (20, 125) | 55 (20, 117) | 60 (19, 165) | 0.265 |
Lac (mmol/L) | 2.2 (1.4, 3.4) | 2.05 (1.3, 3.1) | 3.7 (2.5, 6.6) | <0.001 |
PT (s) | 12.6 (11.7, 13.9) | 12.6 (11.7, 13.7) | 13.2 (12, 16.1) | 0.005 |
INR | 1.12 (1.03, 1.22) | 1.12 (1.03, 1.21) | 1.17 (1.03, 1.38) | 0.036 |
APTT (s) | 34.5 (29.7, 40.9) | 34.3 (29.4, 40.6) | 37.1 (30.8, 46.6) | 0.004 |
Fib (g/L) | 3.1 (2.14, 4.18) | 3.2 (2.27, 4.25) | 2.02 (1.48, 3.06) | <0.001 |
ALT (U/L) | 22 (14, 36) | 21 (14, 34) | 29 (17, 64) | <0.001 |
TBIL (μmol/L) | 7.27 (4.7, 11.91) | 7.34 (4.7, 11.8) | 7.01 (4.75, 14.24) | 0.523 |
DBIL (μmol/L) | 2.1 (1.31, 3.67) | 2.1 (1.32, 3.52) | 2.23 (1.2, 4.82) | 0.285 |
LDH (U/L) | 492 (335, 850) | 485 (334, 831) | 547 (366.5, 1057) | 0.100 |
γ-GT (U/L) | 16 (11, 30) | 14.5 (11, 28) | 24 (14, 43) | <0.001 |
Cr (μmol/L) | 26 (20, 34) | 25 (20, 33) | 30 (20, 44) | 0.005 |
BUN (mmol/L) | 3.4 (2.5, 4.7) | 3.3 (2.4, 4.4) | 4.5 (3.1, 8.5) | <0.001 |
CK-MB (U/L) | 22 (14, 41) | 21 (13, 38) | 42 (19.5, 79.5) | <0.001 |
PLT (×109/L) | 219 (119, 305) | 226 (132.5, 309) | 113 (29, 225) | <0.001 |
WBC (×109/L) | 6.25 (4.59, 8.74) | 6.25 (4.64, 8.63) | 6.49 (3.94, 10.52) | 0.815 |
CRP: C-reactive protein; Lac: lactate; PT: prothrombin time; INR: international normalized ratio; APTT: activated partial thromboplastin time; Fib: fibrinogen; ALT: alanine aminotransferase; TBIL: bilirubin; DBIL: direct bilirubin; LDH: lactate dehydrogenase; γ-GT: γ-glutamyl transpeptidase; Cr: creatinine; BUN: blood urea nitrogen; CK-MB: creatine kinase-MB; PLT: platelet; WBC: white blood cell. Results are presented as median (interquartile range (IQR)).